Atlas Trials

Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol

Clinical trial NCT04400591 · AVAILABLE

Trial details

NCT number
NCT04400591
Sponsor
Juno Therapeutics, a Subsidiary of Celgene
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Lymphoma, Large B-Cell, Diffuse

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.